TG Therapeutics

+$0.02 (+0.06%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell TGTX and other stocks, options, and ETFs commission-free!

About TGTX

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib.

CEO
Michael Sean Weiss
Employees
272
Headquarters
New York, New York
Founded
1993

TGTX Key Statistics

Market Cap
5.31B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.53M
High Today
$34.96
Low Today
$33.53
Open Price
$34.37
Volume
1.59M
52 Week High
$56.74
52 Week Low
$16.56

TGTX Earnings

-$0.73
-$0.49
-$0.24
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.49 per share
Actual
-$0.69 per share
Replay Earnings Call

You May Also Like

YORW
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure